Arcturus Therapeutics Holdings Inc. (the "Company", "Arcturus", Nasdaq: ARCT), a commercial messenger RNA medicines company ...

Opus Genetics, Inc. (Nasdaq: IRD), a clinical-stage ophthalmic biopharmaceutical company developing gene therapies for the ...

The father-of-four chef, 58, was diagnosed with Type I bipolar disorder in 2023. He divides his time between Berkshire and ...

A US study finds eight psychiatric disorders share genetic roots, offering hope for unified treatment approaches.

Sleep disorders may lead to structural brain changes, cognitive decline, and neurological disease. Here’s what science says about the risk.

More than one quarter of the medcines cleared by the FDA’s main review office since 2015 have been cancer drugs, a tally that ...

To address possible misclassification in the diagnosis of schizoaffective disorder (SZA), we reanalysed the genome scan data on chromosomes 8 and 13, treating the 10 SZA subjects (in nine families ...

A proof-of-concept study shows that CRISPR-Cas9 can eliminate extra chromosome copies in Down syndrome cells. The method restores normal gene function but is not yet ready for human trials. Scientists ...

Gene editing techniques may eventually allow trisomy to be treated at the cellular level, according to an in vitro proof-of-concept study. Down syndrome is caused by the presence of a third copy ...

which is more than 2 copies of a chromosome, as in trisomy 21, Down's syndrome) Translocation Shift of a piece of a chromosome to another chromosomal location Deletion Loss of a segment of a ...

The resultant chromosomes are lacking in some genetic information and have excessive amounts of some. Many important clinical conditions like Down syndrome and chronic myelogenous leukemia result ...